What We Know to Date About Early Treatment With Biologics in Severe Asthma: A Scoping Review About the Use of Biologics in Severe Asthma and Possible Parallels With Early Rheumatoid Arthritis
Data suggests that the more preventive approach may lead to improved results. The scarcity of scientific evidence highlights the importance of pursuing this line of research.
Authors
- Luis Pérez de Llano (ORCID: https://orcid.org/0000-0003-2652-6847)
- Elisa Luzón (ORCID: https://orcid.org/0009-0003-3007-8255)
- Francisco Ramos-Lima
- Mary Ann Bonilla
- J C Miralles
Institutions
- Hospital Universitario La Paz (ES)
- Hospital Reina Sofía de Murcia (ES)
- Hospital Universitario Lucus Augusti (ES)
- AstraZeneca (Spain) (ES)
Publication Details
- Journal
- Open Respiratory Archives
- Published
- 2025-02-28
- DOI
- https://doi.org/10.1016/j.opresp.2025.100418
- Citations
- 2
- Primary Topic
- Asthma and respiratory diseases
- Type
- article
- Field-Weighted Citation Impact
- 2.33
Funders
- AstraZeneca España